Trial Results Not Published – Dr. Burzynsky

For the first time in history, a private individual was granted the ability to enter the federal drug approval process for a proprietary cancer therapy. The entire process is being funded without any financial support from the American Government, the Pharmaceutical Industry or The Cancer Establishment.

On November 26, 2012 (6:13:08 am), the results of the phase III study on antineoplastons was released to The Lancet for publication, showing over 8 – 16 years survival using antineoplastons to treat a rare brain cancer.

On November 26, 2012 (8:22:57 am) the study was rejected by The Lancet from publication. ” … we have now had time to consider your manuscript… We have decided not to publish it because we believe the message would be better elsewhere.” It appears to have only taken a little over two hours to “consider” publishing.

Earlier, on November 19, 2012: The Texas Medical Board dismissed its motion to revoke Dr. Burzynsky’s medical license after four years of trying.

January 7, 2013: The FDA physically enters Dr. Burzynsky’s Clinic, and demands that all information pertaining to antineoplastons be removed from their website , and that no new patients be provided treatment on American soil (temporary hold). The FDA remained on site for 45 days reviewing data collected over 25 years, finding no evidence of either safety or efficacy violations with Antineoplastons.

The relationship between the FDA and Dr. Burzynsky has a rich legal history which began in 1983 when the “FDA takes Dr. Burzynski to court in a civil action to stop him from manufacturing and using antineoplastons. ” The FDA has since convened 4 grand juries without a grand jury indictment.

While in Japan, a study testing for the “safety” of antineoplastons (1995), which is a Phase I type of test was positive, yet in December of 2012, the Kurume Medical University announced :

“We can’t go any further with these clinical trials allowing antineoplastons to gain market approval exclusively for the Japanese people due to the United States FDA and the power they have over the world market. The FDA would retaliate against any Japanese pharmaceutical company who would try to get antineoplastons approved in Japan by no longer approving their other drugs for market in the USA” – Hideaki Tsuda, MD

Phase II Results (March 2003)

One would think that if there was progress in the treatment of such serious cancers, the FDA would be expanding research in that area. They apparently do not agree with Dr. Burzynsky.

Why do you Use Aspartame?

Aspartame, an artificial sweetener marketed under the names of NutraSweet® and Equal® and now AminoSweet (marketed in Europe as a natural product) is marketed to reduce weight. A recent study published this week from a Purdue researcher, suggests the opposite. There are massive studies on this product, and to this day, the battle between health advocates and the food industry rages on. Do you use Aspartame to lose weight?

“85% of all complaints registered with the Food and Drug Administration (FDA) concerns aspartame’s adverse reactions.”

“Currently, aspartame is found in more than 6,000 products and is consumed by over 200 million people around the world.”

A 60 minutes report from December of 1996 had some highlights listed below:

1. Debate began in 1975 about its effect on causing brain cancer.
2. In 1980, the FDA had 2 separate panels (3 scientists each) evaluate the product release. Both panels said the product should not be released without further testing.
3. In 1981, Dr. Arthur Hall Hayes was appointed the Commissioner of the FDA. He over-ruled both panels and approved the release. Two years after it was approved for dry products, it was approved for soft drinks. Hayes left the FDA a few months later to take a job for the PR firm that works with Searle, the then owner of Aspartame. (Dr. Hall was selected by Donald Rumsfeld, former CEO of J.D. Searle, who in 1981 was on Ronald Reagan’s transition team. The History of Aspartame)
4. Out of 164 tests conducted on Aspartame, 74 funded by industry, 100% found it to be safe. Of the 90 independent studies, 83 identified a problem.

Bittersweet: The Truth About Aspartame

Aspartame and brain tumor links in 2005 (methanol and formaldehyde)

Data from 2012 :

Brain tumors are the:

Second leading cause of cancer-related deaths in children (males and females) under age 20 (leukemia is the first).

Second leading cause of cancer-related deaths in males ages 20-39 (leukemia is the first).

Fifth leading cause of cancer-related deaths in females ages 20-39.

Eating a healthy diet during brain cancer treatment, and before can be found here.

“Most people think they are a victim of their genes, helpless to stave off some of the most dreaded diseases. We aren’t helpless at all; in fact, the power is largely in our hands. It’s on our forks, actually.”